Intuitive Surgical, Inc.

ISRG Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.

426.70 1.16 −0.27%
Market cap
$151.2B
P/E
48.3×
Fwd P/E
46.4×
Dividend yield
—
F-score
7/9
Altman Z
50.09
Beneish M
−2.43
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

58.16 70.71 55.08 44.99
P/S ratio
16.59 20.08 15.46 12.76
P/FCF ratio
70.22 81.16 56.80 43.08
P/Operating CF
189.63 226.48 179.41 132.72
P/B ratio
9.36 11.27 9.30 7.70
EV/Sales
16.08 19.49 15.03 12.29
EV/EBITDA
45.00 54.16 40.20 31.88
EV/FCF
68.06 78.77 55.23 41.49
Current Ratio
4.73 4.87 4.61 4.96
Net Debt/EBITDA
(5.13) (5.61) (4.32) (4.37)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
1.72% 1.41% 1.82% 2.22%
Free Cash Flow Yield
1.42% 1.23% 1.76% 2.32%
Free Cash Flow per Share
2.06 2.05 2.41 2.68
Book value per Share
47.79 50.27 49.58 51.67
Free Cash Flow
735.60 730.00 854.60 948.40
EV/EBIT
54.89 66.61 49.36 39.29
Other line items

Show all line items

Columns are period end dates